Holen Sie sich die Stockscreener-App
1.31
2.24%
-0.03
Handel nachbörslich:
1.31
Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten
Cardiol Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cardiol Therapeutics Reports Q2 2025 Financial Results Amid Rising Losses - TipRanks
The Significance of Moving Averages in Cardiol Therapeutics Inc Inc. (CRDL) Price Performance - investchronicle.com
Healthcare Analysts Bullish on SI-Bone, Delcath Systems, and Cardiol Therapeutics - AInvest
Chart based analysis of Cardiol Therapeutics Inc. trendsJuly 2025 Update & Free Real-Time Market Sentiment Alerts - Newser
What technical models suggest about Cardiol Therapeutics Inc.’s comebackPortfolio Risk Summary & Entry and Exit Point Strategies - Newser
How to integrate Cardiol Therapeutics Inc. into portfolio analysis toolsJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - Newser
Relief Rally in Cardiol Therapeutics Inc. Stock — Can It Hold [Insider Selling]Low Drawdown Trading Strategies - 선데이타임즈
Will Cardiol Therapeutics Inc. stock go up soon [2025 Trading Volume Trends]Free Community Trade Idea Sharing Platform - Newser
Why is Cardiol Therapeutics Inc. stock going downBig Return Within 7 Days - thegnnews.com
Analyzing Cardiol Therapeutics Inc. with multi timeframe chartsAI-Based Stock Behavior Forecast Engine - Newser
Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH) - TradingView
Analyzing drawdowns of Cardiol Therapeutics Inc. with statistical toolsWeekly Growth Portfolio Performance Summary - Newser
Pharmaceutical Company Discovers Breakthrough Heart Treatment in Canada - streetwisereports.com
Canadian Pharmaceutical Company Discovers Breakthrough Cardiovascular Treatment - streetwisereports.com
Biotech Announces Topline Results From Cardiovascular Drug Trial - streetwisereports.com
Cardiol Therapeutics to Participate in Fireside Chat at Canaccor - GuruFocus
Cardiol Therapeutics to Present at Canaccord Genuity Conference - TipRanks
Fluor Acknowledges Court Decision on Santos’ Gladstone LNG Project - The Globe and Mail
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference - Newsfile
Cardiol Therapeutics Reveals Latest Heart Disease Treatment Progress at Major Growth Conference - Stock Titan
Moving Average Trends for Cardiol Therapeutics Inc. Stock: What They IndicateEntry Confirmation Based on Volatility Analysis - Newser
Canadian Pharma Finds Promising Cardiovascular Breakthrough - streetwisereports.com
Watch for Trend Continuation in Cardiol Therapeutics Inc. Next WeekPortfolio Diversification Stock Ideas From Experts - beatles.ru
Cardiol Therapeutics (CRDL) Expected to Announce Earnings on Monday - Defense World
(CRDL) Risk-Controlled Trading Report (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics CRDL 2025Q2 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
Cardiol Therapeutics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Is Cardiol Therapeutics a buy? - Cantech Letter
Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure - Yahoo Finance
Cardiol Therapeutics Announces US Listing - thedeepdive.ca
Cardiol Therapeutics shares rise 7.48% premarket after positive ARCHER trial results for CardiolRx™. - AInvest
Cardiol falls after mid-stage data for heart disease treatment - MSN
Roth bullish on Cardiol, says trial results enough to attract larger partner - TipRanks
Quantum Biopharma Ltd. shares rise 1.19% after-hours following Cardiol Therapeutics' positive ARCHER trial results. - AInvest
Cardiol data readout positive and not priced in, says H.C. Wainwright - TipRanks
Cardiol Therapeutics’ Cannabidiol Formulation Reduced Inflammation—Phase II Topline Data Ignites the Race to Treat Acute Myocarditis - InvestorNews
Cardiol ARCHER study not statistically significant, says Canaccord - TipRanks
Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Barchart.com
Cardiol Therapeutics Reports Promising Phase II Trial Results for CardiolRx™ in Acute Myocarditis - TipRanks
Cardiol falls after mid-stage data for heart disease drug - Seeking Alpha
Cardiol Therapeutics Announces Topline Results from the Phase II - GuruFocus
(CRDL) Trading Report (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Inc. Recovery Gathers Momentum on Chart SignalsWatchlist for Smart Swing Trading Updated - beatles.ru
Is Cardiol Therapeutics Inc. in Accumulation Phase NowOptimized Watchlist With Daily Adjustments Launched - metal.it
What is the dividend policy of Cardiol Therapeutics Inc. stockGet daily updates on promising stocks - Jammu Links News
Published on: 2025-08-04 07:27:14 - metal.it
What institutional investors are buying Cardiol Therapeutics Inc. stockRobust investment performance - Jammu Links News
How does Cardiol Therapeutics Inc. compare to its industry peersCapitalize on stocks with high profit margins - Jammu Links News
(CRDL) Comprehensive Trading Strategy Report (CRDL:CA) - news.stocktradersdaily.com
What makes Cardiol Therapeutics Inc. stock price move sharplyFree Trend-Following Techniques - Jammu Links News
What are the latest earnings results for Cardiol Therapeutics Inc.Maximize your portfolio’s growth with expert tips - Jammu Links News
How volatile is Cardiol Therapeutics Inc. stock compared to the marketAccess high-yield investment alerts now - Jammu Links News
Should I hold or sell Cardiol Therapeutics Inc. stock in 2025Free Buy/Sell Signal Notifications - Jammu Links News
How strong is Cardiol Therapeutics Inc. company’s balance sheetFree Predictions - Jammu Links News
Does Cardiol Therapeutics Inc. stock perform well during market downturnsMaximize gains with expert analysis - Jammu Links News
What analysts say about Cardiol Therapeutics Inc. stockRapidly expanding wealth - Jammu Links News
Is Cardiol Therapeutics Inc. a growth stock or a value stockUncover the best stocks for explosive growth - Jammu Links News
Is Cardiol Therapeutics Inc. stock overvalued or undervaluedDiscover stocks with superior performance - Jammu Links News
What is Cardiol Therapeutics Inc. company’s growth strategyBuild a winning portfolio with smart picks - Jammu Links News
Why is Cardiol Therapeutics Inc. stock attracting strong analyst attentionUnlock daily stock market insights for success - Jammu Links News
Head to Head Review: Achieve Life Sciences (NASDAQ:ACHV) & Cardiol Therapeutics (NASDAQ:CRDL) - Defense World
2.80%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):